BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24347475)

  • 1. Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times.
    Squires MH; Hanish SI; Fisher SB; Garrett C; Kooby DA; Sarmiento JM; Cardona K; Adams AB; Russell MC; Magliocca JF; Knechtle SJ; Staley CA; Maithel SK
    J Surg Oncol; 2014 May; 109(6):533-41. PubMed ID: 24347475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time.
    Mehta N; Dodge JL; Grab JD; Yao FY
    Hepatology; 2020 Mar; 71(3):943-954. PubMed ID: 31344273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?
    Koniaris LG; Levi DM; Pedroso FE; Franceschi D; Tzakis AG; Santamaria-Barria JA; Tang J; Anderson M; Misra S; Solomon NL; Jin X; DiPasco PJ; Byrne MM; Zimmers TA
    Ann Surg; 2011 Sep; 254(3):527-37; discussion 537-8. PubMed ID: 21865950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
    Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
    Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
    Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis.
    Sourianarayanane A; El-Gazzaz G; Sanabria JR; Menon KV; Quintini C; Hashimoto K; Kelly D; Eghtesad B; Miller C; Fung J; Aucejo F
    HPB (Oxford); 2012 May; 14(5):325-32. PubMed ID: 22487070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic resection for transplantable hepatocellular carcinoma for patients within Milan and UCSF criteria.
    Chua TC; Saxena A; Chu F; Morris DL
    Am J Clin Oncol; 2012 Apr; 35(2):141-5. PubMed ID: 21336092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.
    Jiang L; Liao A; Wen T; Yan L; Li B; Yang J
    Transpl Int; 2014 Jun; 27(6):562-9. PubMed ID: 24606007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.
    Goldberg D; French B; Abt P; Feng S; Cameron AM
    Liver Transpl; 2012 Apr; 18(4):434-43. PubMed ID: 22271656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.
    Zaydfudim VM; Vachharajani N; Klintmalm GB; Jarnagin WR; Hemming AW; Doyle MB; Cavaness KM; Chapman WC; Nagorney DM
    Ann Surg; 2016 Oct; 264(4):650-8. PubMed ID: 27433910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does meeting the Milan criteria at the time of recurrence of hepatocellular carcinoma after curative resection have an impact on prognosis?
    Kim HS; Yi NJ; Kim JM; Hong SK; Kwon CHD; Joh JW; Lee KW; Suh KS
    ANZ J Surg; 2019 Mar; 89(3):216-222. PubMed ID: 30384395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score.
    Vitale A; Huo TL; Cucchetti A; Lee YH; Volk M; Frigo AC; Cescon M; Tuci F; Pinna AD; Cillo U
    Ann Surg Oncol; 2015; 22(6):1901-7. PubMed ID: 25234023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions.
    Schmitt TM; Kumer SC; Shah N; Argo CK; Northup PG
    Ann Hepatol; 2010; 9(4):390-6. PubMed ID: 21057157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Resection and Liver Transplant in Treatment of Hepatocellular Carcinoma.
    Aksoy SO; Unek T; Sevinc Aİ; Arslan B; Sirin H; Derici ZS; Ellidokuz H; Sagol O; Agalar C; Astarcıoglu İ
    Exp Clin Transplant; 2020 Nov; 18(6):712-718. PubMed ID: 29957158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention-to-treat principle.
    Foltys D; Zimmermann T; Kaths M; Strempel M; Heise M; Hoppe-Lotichius M; Weiler N; Scheuermann U; Ruckes C; Hansen T; Pitton M; Otto G
    Clin Transplant; 2014 Jan; 28(1):37-46. PubMed ID: 24171713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcome of Liver Resection Versus Transplantation for Hepatocellular Carcinoma in a Region Where Living Donation is a Main Source.
    Sung PS; Yang H; Na GH; Hwang S; Kang D; Jang JW; Bae SH; Choi JY; Kim DG; Yoon SK; You YK
    Ann Transplant; 2017 May; 22():276-284. PubMed ID: 28473688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.